Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin
by Melly Alazraki on Oct.25, 2010, under Towing
Arena Pharmaceuticals announced, as expected, the U.S. Food and Drug Administration did not approve its weight loss drug Lorcaserin for patients who are obese and overweight because the potential risks outweigh the minimal efficacy.
Continue reading Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin
Arena Shares Finish Higher After FDA Rejects Obesity Drug Lorcaserin originally appeared on DailyFinance on Mon, 25 Oct 2010 16:00:00.
Filed Under: Company News, Abbott
-
You Can Reach Us At:
For All Of Your Towing and Recovery Needs.
Tele: (847) 587-6076
Fax: (847) 587-8610 Some Of Our Pics
